PARP Inhibition in Prostate Cancer: An Evolving Paradigm and the Role of the Practicing Urologist

Download slides and watch an on-demand webcast featuring an expert urologist and medical oncologist on how urologists can implement best practices for testing and identifying patients with prostate cancer likely to benefit from PARP inhibitor&ndash based monotherapy and combination therapy.

Share

Program Content

No activities added yet

No activities added yet

Provided by

ProCE Banner

Supporters

Supported by an educational grant from

Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC